Ana Marisa Chudzinski-Tavassi
Overview
Explore the profile of Ana Marisa Chudzinski-Tavassi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
568
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Buri M, Garavelli G, Vigerelli H, de Souza M, Maia Lobba A, Ghidelli-Disse S, et al.
PLoS One
. 2025 Mar;
20(3):e0318119.
PMID: 40072951
The effective delivery of drugs remains a major challenge in the development of new therapeutic molecules. Several strategies have been employed to address this issue, with cell-penetrating peptides (CPPs) standing...
2.
Almeida T, Giannotti K, Ribeiro Silva L, Marques-Porto R, DeOcesano-Pereira C, Camargo L, et al.
Front Pharmacol
. 2024 Aug;
15:1425446.
PMID: 39114354
Melanoma, a highly aggressive skin cancer originating in melanocytes, poses a significant threat due to its metastatic potential. While progress has been made in treating melanoma with targeted therapies and...
3.
Bufalo M, Almeida M, Jensen J, DeOcesano-Pereira C, Lichtenstein F, Picolo G, et al.
Cells
. 2024 Jul;
13(13).
PMID: 38995017
In the original publication [...].
4.
Dias D, Souza de Souza K, Moslaves I, Buri M, Luiz Soares Basilio D, Teixeira Espinoca I, et al.
Purinergic Signal
. 2024 Jul;
PMID: 38958820
Snake bites are a severe problem in the countryside of Brazil and are usually attributed to snakes of the genera Bothrops, Crotalus, and Lachesis. Snake venom can release ectoenzymes and...
5.
Alvarez-Flores M, Correia Batista I, Villas Boas I, Bufalo M, de Souza J, Oliveira D, et al.
Toxicon
. 2023 Dec;
238:107568.
PMID: 38110040
Most anti-inflammatory drugs currently adopted to treat chronic inflammatory joint diseases can alleviate symptoms but they do not lead to remission. Therefore, new and more efficient drugs are needed to...
6.
Dias de Oliveira F, Antonioli E, Dias O, de Souza J, Agarwal S, Chudzinski-Tavassi A, et al.
Int J Mol Sci
. 2023 Nov;
24(21).
PMID: 37958526
Transplanted mesenchymal stromal cells (MSCs) exhibit a robust anti-inflammatory and homing capacity in response to high inflammatory signals, as observed in studies focused on rheumatic diseases that target articular cartilage...
7.
Vallone V, Borzone F, Martinez L, Giorello M, Choi H, Dimase F, et al.
Front Oncol
. 2023 Mar;
13:1073793.
PMID: 36890825
Introduction: Osteolytic bone metastasis in advanced breast cancer stages are a major complication for patient´s quality life and a sign of low survival prognosis. Permissive microenvironments which allow cancer cell...
8.
de Melo T, Trevisan-Silva D, Alvarez-Flores M, Gomes R, de Souza M, Valerio H, et al.
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142365
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for the severe pandemic of acute respiratory disease, coronavirus disease 2019 (COVID-19), experienced in the 21st century. The clinical manifestations...
9.
Andrade S, Batalha-Carvalho J, Curi R, Wen F, Covas D, Chudzinski-Tavassi A, et al.
Front Immunol
. 2022 Jul;
13:871874.
PMID: 35898497
The COVID-19 pandemic caused by the severe acute syndrome virus 2 (SARS-CoV-2) has been around since November 2019. As of early June 2022, more than 527 million cases were diagnosed,...
10.
Alvarez A, Alvarez-Flores M, DeOcesano-Pereira C, Goldfeder M, Chudzinski-Tavassi A, Moreira V, et al.
Front Mol Biosci
. 2022 Jul;
9:904737.
PMID: 35847970
The pursuit of better therapies for disorders creating deficiencies in skeletal muscle regeneration is in progress, and several biotoxins are used in skeletal muscle research. Since recombinant proteins derived from...